520 Pandemic Feature - v4 - FINAL - R1_Pages 5 / 6 / 20 3 : 54 PM Page 3 The experience of the last two months , with the Red Cross to secure the needed while traumatic for many who convalescent plasma . ” are working on the front lines and those who have lost In addition to participating in the Mayo loved ones , also brings stories of success . Clinic research study , Inspira’s Clinical People are recovering and research into Research Office is making a separate and RESPONDING TO THE new treatments is underway . additional effort to inform recovered COVID - PRESSURE Virtua and Inspira Health are partici - 19 patients that they may meet specific The health care industry steps up pating in a program led by the Mayo Clinic eligibility criteria to donate and subsequently when we need it most . that is evaluating the use of convalescent register with the Red Cross as plasma BY LIZ HUNTER plasma on the immune systems of critically donors . According to Abate , many of the ill patients . This plasma is collected from IN THE EARLY DAYS OF THE PANDEMIC , people they are contacting are excited by donors who have recovered from the coro - health care organizations were bracing the opportunity to help others . navirus and possess antibodies . In April , for impact , dealing with unknowns and Like most things in medicine , says Virtua performed the first two transfusions preparing for the worst . Brian Sweeney , Blaber , there are risks associated with of this type in New Jersey on a man and interim president of Jefferson Health New every course of action . “ For those first two woman in their early 60s , and reported Jersey — whose Cherry Hill hospital cared plasma recipients , the potential reward — their recovery and expected return home . for the first positive case in South Jersey — saving their lives — far outweighed any “ Convalescent plasma therapy for says he witnessed firsthand the magnitude risk . But that does not mean it is the best COVID - 19 patients is both intriguing and of caring for that patient . “ As it spread , it or most appropriate option for everyone . unproven , ” Blaber says . “ We are delighted was challenging in terms of coordinating The same can be said for remdesivir , an by the recoveries of our initial two plasma care , ” he says . “ We had to reconfigure to experimental antiviral drug that was orig - recipients and glad prepare for a surge , but the slow ramp - up inally designed to combat Ebola . There that Virtua can con - in South Jersey gave us time to plan and have been some early reports of its effec - tribute to the national research on this we are constantly scouring for all evi - tiveness , but only time will tell if there are treatment option . However , far more data dence - based practices and adopting them proven clinical benefits , ” he says . is necessary before we can speak to the locally . ” Health care organizations are leveraging efficacy of this intervention . ” Although things have been more man - technology in innovative ways , and it has ageable in our become a valuable tool for treatment area , Sweeney says that during the pandemic , potentially setting doesn’t necessarily mean there has been up telehealth platforms a slowdown . “ Some days look like there’s in particular as been a flattening , but then the next day the new norm . you have more . … It seems it hasn’t slowed For instance , Inspira launched a ded - IN A WAY , ACCESS yet , but it’s also not growing at a fast rate . ” icated COVID - 19 chatbot , dubbed “ Rosie , ” Dr . Reginald Blaber , executive vice pres - accessible from the Inspira Health home - TO CARE ACTUALLY ident and chief clinical officer of Virtua page , which walks people who think they INCREASED AS Health , says his organization is seeing signs have been exposed through a series of “ of a light at the end of the tunnel . “ The questions to determine their next steps . A TRANSPORTATION number of patients with COVID - 19 illness 16 - day self - monitoring tool was also added , admitted to our five hospitals has leveled allowing physicians to check in on a large ISSUES OR COMMUTE off and there are indicators that it may be sample of patients and their progress . TIMES WERE in its decline , ” he says . “ The surge that Dr . Joshua S . Coren , professor and experts once projected now seems signif - chair , family medicine , Rowan University ELIMINATED . icantly diminished . … I credit this to the School of Osteopathic Medicine ( SOM ) , THE TELEHEALTH luxury of time and the widespread stay - says COVID - 19 impacted the department’s at - home and social distancing measures . ” entire business model . All normal opera - TECHNOLOGY ENABLES For now , tions had to be revised , and they continue this has meant that hospital US TO STILL SEE to adapt . As a department that provides beds , ventilators , PPE and other supplies primary care and therapeutic mental have remained available among South OUR PATIENTS FACE health services to the community , con - Jersey’s health care providers . In terms of TO FACE . ” tinuing its high level of care was essential . testing kits , Blaber says their lack of avail - Switching to telehealth quickly made it ability is less of an issue now . Virtua reports — Dr . Joshua S . Coren , possible . it is testing more than 140 people daily at Rowan University School of Osteopathic Medicine “ We its testing locations in Burlington and were able to maintain access for Camden counties , and Sweeney says Jef - our patients in a safe environment while ferson is performing about 750 tests a reducing risk of transmission of COVID - week between its three sites as well . “ The scientific community is cautious - 19 to patients and employees , ” Coren says . “ It is especially important that testing ly optimistic that convalescent serum “ In a way , access to care actually increased kits are available for health care employees might prove beneficial to people with as transportation issues or commute times and first responders . They are vital during severe or life - threatening COVID - 19 , ” says were eliminated . The telehealth technology the pandemic , and testing allows us to Dr . Sami Abate , director of clinical research enables us to still see our patients face to know if they are available to report to at Inspira Health . “ We have identified six face , which allows us to continue building work or if they need to stay home and patients in our hospitals who meet the relationships with them . ” quarantine , ” says Blaber . criteria to participate , and we are working The experience was also invaluable to SOUTH JERSEY MAGAZINE volume 17 issue 2 SouthJerseyMagazine.com 32 |